Mass High Tech
KOLLTAN PHARMACEUTICALS INC
Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!
About:
Kolltan Pharmaceuticals is developing novel therapeutics targeting proprietary discoveries in the mechanisms of receptor tyrosine kinase activation.
Headlines from Mass High Tech about KOLLTAN PHARMACEUTICALS INC
Print this Listing
Product Information
| Industry Classification | Biopharma/Biotechnology |
| Primary Business Focus | Biotechnology - Pharmaceutical |
Details
| Year Established | 2007 |
| Ownership Type | Private |
Contacts
| Michael Schmertzler | CEO/President | |||
| Stanley Choy | VP Finance/Treasurer | |||
| Yaron Hadari | VP Research | |||
| Bradford Middlekauff | General Counsel | |||
| Arthur Altschul | Co-Founder/Chairman | |||
| Joseph Schlessinger | Co-Founder/Director/Chairman Scientific Adv Board |
* Downloads will not contain Personnel E-mail addresses
Search the Directory
Company Overview
| Focus | Biotechnology - Pharmaceutical |
| Location | New Haven, CT |
| Website | http://www.kolltan.com |
| Revenue | Subscriber access only |
Contact Information
| Address |
300 George St Suite 530 New Haven, CT, 06511 |
| Phone | 203-773-3000 |
| Fax | 203-773-1300 |
| Subscriber access only | |
| Website | www.kolltan.com |
New England Tech Directory
| Browse
| Subscribe
| Advertise
| Networking
| About Us
| Search
| 
RSS Feeds
| 
| Directory License
| Update User Info
| Directory Privacy Policy
| Logout
© 2012 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of bizjournals.
Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com
Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.